Findings

What do systematic reviews say?

2,191 questions · 2,354 findings · 362 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 323 · 13.7%GRADE not reported 382 · 16.2%Very low 555 · 23.6%Low 597 · 25.4%Moderate 345 · 14.7%High 152 · 6.5%

Balneotherapy vs no treatment

Health‐related quality of life –CIVIQ2 Scale: 20–100 · people with chronic venous insufficiency

1 finding from 1 review

Balneotherapy for chronic venous insufficiency 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 153 participants
Very low

Balneotherapy vs no treatment

Pain (VAS, scale 0–10, lower is better) · people with chronic venous insufficiency

1 finding from 1 review

Balneotherapy for chronic venous insufficiency 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 354 participants
Low

Balneotherapy vs no treatment

Oedema(leg circumference in cm, lower is better) · people with chronic venous insufficiency

1 finding from 1 review

Balneotherapy for chronic venous insufficiency 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 369 participants
Very low

Balneotherapy vs no treatment

Skin pigmentation changes · people with chronic venous insufficiency

1 finding from 1 review

Balneotherapy for chronic venous insufficiency 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 59 participants
Low

Intervention not reported

HEART RATE POST‐intervention (lower = favourable) · preterm infants and their parents

1 finding from 1 review

Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants 2023 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 903 participants
High

Intervention not reported

RESPIRATORY RATE DURING intervention (lower = favourable) · preterm infants and their parents

1 finding from 1 review

Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 750 participants
Moderate

Intervention not reported

RESPIRATOTY RATE POST‐intervention (lower = favourable) · preterm infants and their parents

1 finding from 1 review

Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 636 participants
Moderate

Intervention not reported

HEART RATE DURING intervention (lower = favourable) · preterm infants and their parents

1 finding from 1 review

Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 1014 participants
Moderate

Intervention not reported

Grief in the relatives ICG (0 to 95; > 25 = presence of complicated grief) measured at 12 months TRIG (21 to 105; lower scores indicate higher levels of grief) measured at 3 and 9 months · relatives, patients, and healthcare professionals during resucitation

1 finding from 1 review

Family presence during resuscitation 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 426 participants
Very low

Donepezil vs placebo

Repetitive and restricted behaviour (Sensory Motor subscale of RLRS; raw score means; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Donepezil vs placebo

Irritability · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Donepezil vs placebo

Hyperactivity (Child Behaviour Checklist Attention problems Subscale; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Donepezil vs placebo

General health and function (Severity of Illness subscale of Clinical Global Impression Scale; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Galantamine plus risperidone vs placebo plus risperidone

Social communication (Lethargy/Social withdrawal subscale of the ABC‐C; 0 to 64; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Galantamine plus risperidone vs placebo plus risperidone

Stereotypical behaviours · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Galantamine plus risperidone vs placebo plus risperidone

Irritability · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

Galantamine plus risperidone vs placebo plus risperidone

Hyperactivity · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

Donepezil vs placebo

Overall autism features (total score of RLRS; raw score means; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Donepezil vs placebo

Social communication (Social Relationships subscale of RLRS; raw score means; lower = better) · children and adolescents with a diagnosis of autism

1 finding from 1 review

Acetylcholinesterase inhibitors for autistic spectrum disorders 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

CBT vs TAU

AEs · chronic pain (excluding headache) in adults

It is very uncertain whether CBT changes adverse events (number of people with adverse events) (Lower events… compared with TAU (post‐treatment) (very low certainty).

1 finding from 1 review · compare the 2 reviews

Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults 2023 · Cochrane Headline outcomes only
RR 6 [2.2, 16.4]
1 study · 140 participants
Very low